首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Digestive diseases and sciences

缩写:DIGEST DIS SCI

ISSN:0163-2116

e-ISSN:1573-2568

IF/分区:2.8/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引9525
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
P Van Ouytsel,A Cremer,D Franchimont et al. P Van Ouytsel et al.
Purpose: Even in the absence of active inflammation, patients with inflammatory bowel diseases (IBD) frequently report symptoms consistent with irritable bowel syndrome (IBS), which may lead to restrictive dietary pattern...
Nan Ru,Jian-Cong Feng,Ya-Wei Bi et al. Nan Ru et al.
Purpose: Endoscopic resection (ER) has gradually emerged as an optional treatment method for non-ampullary duodenal lesions (NADLs); however, this procedure is associated with technical challenges and a notable risk of ad...
Arpit Shastri,Sunil Taneja Arpit Shastri
Tuberculosis (TB) continues to represent a major global health concern, particularly in high-burden countries such as India. In patients with cirrhosis, TB presents a distinct clinical challenge owing to cirrhosis-associated immune dysfunct...
Woo-Jeong Shon,Kyung A Kim,Joo Sung Kim et al. Woo-Jeong Shon et al.
Background and aims: Ultra-processed food (UPF) is increasingly consumed worldwide and may influence gut microbial ecology relevant to inflammatory bowel disease (IBD). However, patient-level multi-omics data remains scar...
Elizabeth Spencer,Pooja Kothari,Manasai Agrawal et al. Elizabeth Spencer et al.
Purpose: The objective of this study was to evaluate how gender, academic rank, and race/ethnicity impact general industry payments for pediatric and adult gastroenterologists before and after the COVID-19 pandemic. ...
Samira Mohamad Khalil,Lubna Al-Sharif,Ivanna Diaz et al. Samira Mohamad Khalil et al.
Backgrounds and aims: Metabolic dysfunction-associated steatohepatitis (MASH) with stage F2-F3 fibrosis represents the main target population for emerging pharmacotherapies. However, data on short-term progression to cirr...
Mark R Baniqued,Neha D Shah,Jessica Dominguez et al. Mark R Baniqued et al.
While the exact cause of inflammatory bowel disease (IBD) remains unclear, interactions among several complex mechanisms are thought to contribute to its pathogenesis. One such factor is diet, which has recently been investigated for its ro...
Jason J Pan,Brian H Horwich,Mohamad Chahine et al. Jason J Pan et al.
Metabolic dysfunction-associated steatohepatitis (MASH) is now recognized as the leading cause of cirrhosis, an important risk factor for hepatocellular carcinoma, and a growing indication for liver transplantation. The U.S. Food and Drug A...